Short-term effects of nCPAP on nasal mucociliary clearance and mucus transportability in healthy subjects  by de Oliveira, Luciana R. et al.
ARTICLE IN PRESSRespiratory Medicine (2006) 100, 183–185KEYWORD
Nasal muc
clearance;
Nasal muc
transporta
Nasal CPAP
Frog palat
Saccharin
0954-6111/$ - s
doi:10.1016/j.r
Correspondi
ato´rio de Polu
Medicina da Un
andar sala 1223
Tel.: 55 11 3066
E-mail addr
geraldo.lorenziSHORT COMMUNICATION
Short-term effects of nCPAP on nasal mucociliary
clearance and mucus transportability in healthy
subjects
Luciana R. de Oliveiraa,, Claudia S. Albertini Yagia,
Adelaide C. Figueiredob, Paulo H.N. Saldivaa, Geraldo Lorenzi-Filhoa,baExperimental Air Pollution Laboratory, Faculty of Medicine, University of Sa˜o Paulo, Sa˜o Paulo, Brazil
bPulmonary Division, Faculty of Medicine, University of Sa˜o Paulo, Sa˜o Paulo, Brazil
Received 16 December 2004; accepted 8 March 2005S
ociliary
us
bility;
;
e model;
test
ee front matter & 2005
med.2005.03.042
ng author. Departame
ic- a˜o Atmosfe´rica Exp
iversidade de Sa˜o Pau
, Cerqueira Ce´sar, 0124
7214; fax: 55 11 306800
esses: lurabello@yahoo
@incor.usp.br (L.R. deSummary Nasal mucociliary clearance is a primary defense mechanism of the
upper airways and may be acutely affected by nasal continuous positive airway
pressure (nCPAP). nCPAP treatment is effective and safe. However, it can cause nasal
side effects and contribute to a low compliance to the treatment. The aim of this
study was to investigate the short-term effects of nCPAP on nasal mucociliary
clearance and on mucus transportability of healthy subjects. Eleven healthy subjects
were submitted to 20min of nCPAP (10 cm H2O). Five subjects were also evaluated
before and after 20min of rest on the consecutive study day. Nasal mucociliary
clearance was measured by the saccharin nasal transit time test and nasal mucus was
collected for the in vitro study of mucus transportability by the frog palate model,
both before and after the nCPAP challenge. Saccharin nasal transit time decreased
significantly after nCPAP (9.2976.06min and 4.8375.57min; P ¼ 0:002 before and
after nCPAP respectively). No significant changes were observed on the control day
(11.6677.57min and 12.4075.62min; P ¼ 0:70). Mucus transportability was not
significantly affected by nCPAP. Our results suggest that nCPAP can acutely increase
nasal mucociliary clearance but does not affect in vitro mucus transportability in
healthy subjects.
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Oliveira).Introduction
Nasal mucociliary clearance is a primary defense
mechanism of the upper airways and its efficiency
depends mainly on three factors: the magnitude of
ciliary input; the amount of mucus and depth of theed.
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mucus.1 Situations that modify nasal mucociliary
function are a risk factor for the defense of the
respiratory airways. Alterations of the mucociliary
function are observed with airway exposure to
different stimuli, including ambient pollutant gases,
respiratory disorders, smoking, extreme tempera-
tures and the use of mechanical ventilation.2–4
Nasal continuous positive airway pressure
(nCPAP) is the treatment of choice for patients
with moderate to severe obstructive sleep apnea
but nasal symptoms are often reported during
nCPAP treatment. These symptoms can cause
substantial discomfort to the patients who may
even abandon treatment. However, patients with
sleep apnea syndrome frequently exhibit nasophar-
yngeal symptoms before nCPAP treatment is
started.5 Therefore the reported symptoms may
be influenced by preexisting conditions.6 The
baseline variability in patients may explain the
conflicting results observed after a long term use of
nCPAP on mucociliary clearance.7,8 On the other
hand, the short-term effects of nCPAP on mucocili-
ary clearance have not been investigated.
The aim of this study was to investigate the
short-term effects of nCPAP on healthy volunteers
without the interference of preexisting respiratory
disorders.Methods
Eleven healthy nonsmoking subjects, seven women
and four men (mean age, 25.872.1 years), volun-
teered to enter the study, which was approved by
the research ethics committee of the Faculty of
Medicine—University of Sa˜o Paulo. The study
participants had no history of atopy, nasal com-
plaints or recent episodes of upper airway infection
and denied alcohol intake for at least 48 h prior to
the study. The study was carried out in an air-
conditioned room (mean temperature, 22 1C) and
the subjects were studied while awake and in the
seated position. All subjects were submitted for
20min to a standard CPAP (AutoSets ResMed)
without humidification at 10 cm H2O of pressure
through a nasal mask (Ultra Mirages ResMed). Mask
or mouth leaks were not allowed. Five of the
subjects were also submitted to 20min of rest on
the consecutive study day, as a control day.
Nasal mucociliary clearance was assessed by
the saccharin nasal transit time test (STT test),
as described in details by Salah et al.9 Deposition
of saccharin was under visual control. Nasal
mucociliary clearance was represented by thetime, in minutes, taken for the subjects to perceive
a sweet taste.
Nasal mucus collection allowed the in vitro
investigation of mucus transportability and was
performed by a left nostril scraping with the use of
a fine paintbrush. Mucus transportability was
determined by the frog palate model. Briefly, the
method is a convenient system for studying
mucociliary transport once the frog palate is lined
with a pseudostratified epithelium, similar to the
one found in human conductive airways. The frog
mucus is collected and used as a control. The
velocity of the human mucus samples on the palate
is compared to the velocity of the frog mucus, and
the results are expressed in terms of relative
velocity (human/frog). Under these conditions the
epithelium is ideal (frog palate) and the only
variables which influence mucus transport are the
physical properties of the mucus.10,11
STT was performed after the mucus samples
were obtained from the opposite nostril of all the
subjects. STT and nasal mucus collection were
performed before the nCPAP mask was applied and
after it was taken off at the end of the study and for
five subjects also before and after 20min of rest.
Our results are presented as means7standard
deviation. The values of saccharin time and mucus
relative velocity before and after nCPAP and
control day were compared using Student-paired
t-test.Results
STT decreased significantly after 20min of nCPAP
(P ¼ 0:002). In contrast, STT did not change
significantly on the control day (Fig. 1). Nasal
mucus relative velocity values were not signifi-
cantly different neither before and after nCPAP
(0.9370.35 and 1.0370.39; P ¼ 0:86) nor on the
control day (1.1370.45 and 1.2570.30; P ¼ 0:58).
None of the patients experienced any nasal
symptom during or after the nCPAP challenge.Discussion
Our study showed that the application of nCPAP for
20min increases nasal mucociliary clearance, but
does not affect in vitro mucus transportability in
healthy subjects. Therefore, the increase in muco-
ciliary clearance after nCPAP, is likely to be due to
modifications of ciliary beating frequency and not
due to changes in mucus physical properties.
Interesting enough, subjects did not experience
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Figure 1 Saccharin nasal transit time before and after
nCPAP (n ¼ 11), and before and after the control day
(n ¼ 5).
Effects of nCPAP on nasal mucus clearance 185nasal symptoms during the study, suggesting that
significant physiological responses do occur even
after a short exposure to nCPAP and are not
necessarily related to symptoms.
Rubin et al.12 observed an increase in mucociliary
clearance in asymptomatic smokers mediated by
changes in mucus physical properties. This effect
was probably to compensate for acute epithelial
damage. The improvement of mucociliary clear-
ance after nCPAP may as well represent an
epithelial response to aggression, in our study most
likely mediated by an increase in ciliary beating
frequency. Togias et al.13 have demonstrated that
physical stimulation (inhalation of cold dry air) of
the human airways causes the local release of
inflammatory mediators probably due to changes in
the osmolarity of the extracellular fluid. Several
inflammatory mediators can increase ciliary beat-
ing frequency.14 Nitric oxide (NO) may play a
pivotal role, NO is a regulator of mucociliary
function in the upper airways acting as a local
mediator between the cilia and various ciliostimu-
lators such as substance P and bradykinin.15
We did not investigate the time course of these
effects, and the acute increase in mucociliary
clearance may be lost over time. Extrapolation of
our data to patients requiring nCPAP, in whom a
variety of preexisting diseases is frequently found,
should be careful. We conclude that nCPAP acutelyaffects mucociliary clearance in healthy subjects
even in the absence of symptoms.References
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